Mostrar el registro sencillo del ítem

dc.contributor.authorNicolas-Avila, Jose A. 
dc.contributor.authorAdrover, Jose M 
dc.contributor.authorHidalgo, Andres 
dc.date.accessioned2020-04-23T14:34:54Z
dc.date.available2020-04-23T14:34:54Z
dc.date.issued2017-01
dc.identifier.citationImmunity. 2017; 46(1):15-28es_ES
dc.identifier.issn1074-7613es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9722
dc.description.abstractNeutrophils were among the first leukocytes described and visualized by early immunologists. Prominent effector functions during infection and sterile inflammation classically placed them low in the immune tree as rapid, mindless aggressors with poor regulatory functions. This view is currently under reassessment as we uncover new aspects of their life cycle and identify transcriptional and phenotypic diversity that endows them with regulatory properties that extend beyond their lifetime in the circulation. These properties are revealing unanticipated roles for neutrophils in supporting homeostasis, as well as complex disease states such as cancer. We focus this review on these emerging functions in order to define the true roles of neutrophils in homeostasis, immunity, and disease.es_ES
dc.description.sponsorshipWe acknowledge funding from MINECO (SAF2015-65607-R, SAF2013-49662-EXP and PCIN-2014-103 to A.H; SVP-2014-068595 to J.A.N.-A.; and BES-2013-065550 to J.M.A). The CNIC is supported by the MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505).es_ES
dc.language.isoenges_ES
dc.publisherCell Press es_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAnimals es_ES
dc.subject.meshHomeostasis es_ES
dc.subject.meshHumans es_ES
dc.subject.meshImmunity, Innate es_ES
dc.subject.meshNeoplasms es_ES
dc.subject.meshNeutrophils es_ES
dc.titleNeutrophils in Homeostasis, Immunity, and Canceres_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID28099862es_ES
dc.format.volume46es_ES
dc.format.number1es_ES
dc.format.page15-28es_ES
dc.identifier.doi10.1016/j.immuni.2016.12.012es_ES
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España) 
dc.contributor.funderFundación ProCNIC 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1097-4180es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.immuni.2016.12.012es_ES
dc.identifier.journalImmunityes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen de la Inflamación Cardiovascular y la Respuesta Inmunees_ES
dc.repisalud.institucionCNICes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional